FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mats Remberger

Research Profile

Disorders

Procedures

Living Beings

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Henric Lindqvist; Mats Remberger; Arja Harila-Saari; Jacek Winiarski; Mikael Sundin
Folinic acid supplementation in higher doses is associated with graft rejection in pediatric hematopoietic stem cell transplantation.
Olle Ringdén; Petter Svenberg; Marie Wikström; Charlotta Edeskog; Britta Eriksson; Sigrun Finnbogadottir; Karin Fransson; Katarina Holmberg; Jonas Mattsson; Ruza Milovsavljevic; Brigitta Omazic; Mats Remberger; Britt-Marie Svahn
Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease.
Sofia Berglund; Jens Gertow; Katarina Le Blanc; Per Ljungman; Mats Remberger; Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Jacek Winiarski; Jonas Mattsson
Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mats Remberger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Henric Lindqvist; Mats Remberger; Arja Harila-Saari; Jacek Winiarski; Mikael Sundin
Folinic acid supplementation in higher doses is associated with graft rejection in pediatric hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):325-8.
2013: Olle Ringdén; Petter Svenberg; Marie Wikström; Charlotta Edeskog; Britta Eriksson; Sigrun Finnbogadottir; Karin Fransson; Katarina Holmberg; Jonas Mattsson; Ruza Milovsavljevic; Brigitta Omazic; Mats Remberger; Britt-Marie Svahn
Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):314-20.
2012: Sofia Berglund; Jens Gertow; Katarina Le Blanc; Per Ljungman; Mats Remberger; Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Jacek Winiarski; Jonas Mattsson
Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.
Transplantation 2012;94(10):1066-74.
2012: Ulrica Forslöw; Britt Gustafsson; Katarina LeBlanc; Jonas Mattsson; Ola Blennow; Olle Ringdén; Mats Remberger
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation.
European journal of haematology 2012;89(3):220-7.
2012: Mats Remberger; Britt Gustafsson; Jonas Mattsson; Magnus Persson; Michael Uhlin
Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantation.
Transplant immunology 2012;27(1):59-62.
2012: Michael Uhlin; Mehmet Uzunel; Sofia Berglund; Jens Gertow; Mats Remberger; Olle Ringden; Darius Sairafi; Sarah Thunberg; Jonas Mattsson
Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantation.
Stem cells and development 2012;21(9):1409-17.
2012: Olle Ringdén; H Schouten; S Shrestha; M-J Zhang; G T da Silva; A Dispenzieri; Cesar O Freytes; R P Gale; J Gibson; V Gupta; L Holmberg; R Kamble; H Lazarus; Sagar Lonial; P McCarthy; K Meehan; G A Milone; Mats Remberger; P N Hari
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma.
Bone marrow transplantation 2012;47(6):831-7.
2012: Jens Gertow; Klas Kärre; Jonas Mattsson; Mantas Okas; Mats Remberger; Sofia Berglund; Michael Uhlin
Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantation.
Clinical immunology (Orlando, Fla.) 2012;143(2):134-44.
2012: Britt-Marie Svahn; O Alvin; H Karlsson; Mats Remberger; Olle Ringdén
Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation.
Bone marrow transplantation 2012;47(5):706-15.
2012: K Garming Legert; A Heimdahl; Mats Remberger; O Ringdèn; G Dahllöf
Salivary secretion in children after fractionated or single-dose TBI.
Bone marrow transplantation 2012;47(3):404-10.
2011: Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Göran Dahllöf; Karin Garming-Legert; Helen Karlsson; Mats Remberger; Jonas Mattsson
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.
European journal of haematology 2011;87(6):503-9.
2011: Göran Dahllöf; Karin Garming-Legert; Mats Remberger; Monica Barr Agholme; Biniyam Wondimu; Olle Ringdén
Xerostomia in children and adolescents after stem cell transplantation conditioned with total body irradiation or busulfan.
Oral oncology 2011;47(9):915-9.
2011: Ulrica Forslöw; Gustafsson Thomas; Jonas Mattsson; Mats Remberger
Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(8):1214-21.
2011: Helen Karlsson; Silvia Nava; Mats Remberger; Zuzana Hassan; Moustapha Hassan; Olle Ringdén
N-acetyl-L-cysteine increases acute graft-versus-host disease and promotes T-cell-mediated immunity in vitro.
European journal of immunology 2011;41(4):1143-53.
2011: Réka Conrad; Mats Remberger; Kerstin Cederlund; Lisbeth Barkholt
Cytokine expression in tumors treated with donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation.
Immunotherapy 2011;3(3):443-51.
2011: Mats Remberger; Jonas Mattsson; Richard Olsson; Olle Ringdén
Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure.
Clinical transplantation 2011;25(1):E68-76.
2010: Darius Sairafi; Mats Remberger; Michael Uhlin; Per Ljungman; Olle Ringdén; Jonas Mattsson
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(12):1728-37.
2010: Olle Ringden; Zuzana Hassan; Helen Karlsson; Richard Olsson; Brigitta Omazic; Jonas Mattsson; Mats Remberger
Granulocyte colony-stimulating factor induced acute and chronic graft-versus-host disease.
Transplantation 2010;90(9):1022-9.
2010: Mats Remberger; Jonas Mattsson
C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation.
International journal of hematology 2010;92(1):161-7.
2010: U Forslöw; Mats Remberger; A Nordlander; Jonas Mattsson
The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumonia.
Bone marrow transplantation 2010;45(5):945-50.
2010: Richard Olsson; Mats Remberger; Zuzana Hassan; Brigitta Omazic; Jonas Mattsson; Olle Ringdén
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants.
European journal of haematology 2010;84(4):323-31.
2010: Jonas Mattsson; A Nordlander; Mats Remberger; Michael Uhlin; J Holgersson; Olle Ringdén; D Hauzenberger
Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection.
Bone marrow transplantation 2010;45(2):235-8.
2009: H Omar; Hans Hägglund; Asa Gustafsson-Jernberg; K LeBlanc; Jonas Mattsson; Mats Remberger; Olle Ringdén; Elda Sparrelid; M Sundin; Jacek Winiarski; Z Yun; Per Ljungman
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(5):393-9.
2009: Katarina Le Blanc; A John Barrett; Marie Schaffer; Hans Hägglund; Per Ljungman; Olle Ringdén; Mats Remberger
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1108-15.
2009: Mats Remberger; Berit Sundberg
Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(8):996-9.
2008: Dan Hauzenberger; M Schaffer; Olle Ringdén; Zuzana Hassan; Brigitta Omazic; Jonas Mattsson; A-C Wikström; Mats Remberger
Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Tissue antigens 2008;72(6):549-58.
2008: Olle Ringdén; M Okas; Michael Uhlin; Mehmet Uzunel; Mats Remberger; Jonas Mattsson
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
Bone marrow transplantation 2008;42(10):643-8.
2008: D Sairafi; M Uzunel; Mats Remberger; Olle Ringdén; Jonas Mattsson
No impact of NOD2/CARD15 on outcome after SCT.
Bone marrow transplantation 2008;41(11):961-4.
2008: Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
Lancet 2008;371(9624):1579-86.
2008: Mats Remberger; Jonas Mattsson; Dan Hausenberger; Marie Schaffer; Britt-Marie Svahn; Olle Ringdén
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia.
European journal of haematology 2008;80(5):419-28.
2008: Lisbeth Barkholt; Mats Remberger; Zuzana Hassan; K Fransson; Brigitta Omazic; Britt-Marie Svahn; H Karlsson; M Brune; Moustapha Hassan; Jonas Mattsson; Olle Ringdén
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2008;41(9):785-90.
2008: Britt-Marie Svahn; Mats Remberger; Mona Heijbel; Eva Martell; Marie Wikström; Britta Eriksson; Ruza Milovsavljevic; Jonas Mattsson; Olle Ringdén
Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition.
Transplantation 2008;85(7):1000-7.
2008: Géraldine Giraud; Peter Priftakis; Gordana Bogdanovic; Mats Remberger; M Dubrulle; A Hau; R Gutmark; J Mattson; Britt-Marie Svahn; Olle Ringden; Jacek Winiarski; Per Ljungman; Tina Dalianis
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts.
Bone marrow transplantation 2008;41(8):737-42.
2008: Réka Conrad; Mats Remberger; Kerstin Cederlund; Olle Ringdén; Lisbeth Barkholt
A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Haematologica 2008;93(2):265-72.
2008: A-C Norlin; D Sairafi; Jonas Mattsson; Per Ljungman; Olle Ringdén; Mats Remberger
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Bone marrow transplantation 2008;41(3):267-73.
2008: Mats Remberger; Jonas Mattsson; Zuzana Hassan; N Karlsson; K LeBlanc; Brigitta Omazic; M Okas; D Sairafi; Olle Ringdén
Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
Bone marrow transplantation 2008;41(4):399-405.
2007: Anders Björklund; Johan Aschan; Myriam Labopin; Mats Remberger; Olle Ringden; Jacek Winiarski; Per Ljungman
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation.
Bone marrow transplantation 2007;40(11):1055-62.
2007: Lisbeth Barkholt; Mats Remberger; H Bodegård; Olle Ringdén; Y Böttiger
Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2007;40(7):683-9.
2007: Zuzana Hassan; Mats Remberger; Petter Svenberg; Maria Elbander; Brigitta Omazic; Jonas Mattsson; Réka Conrad; Britt-Marie Svahn; Anders Ahlgren; Darius Sairafi; Johan Aschan; Katarina Le Blanc; Lisbeth Barkholt; Olle Ringdén
Hemorrhagic cystitis: a retrospective single-center survey.
Clinical transplantation 2007;21(5):659-67.
2007: Mats Remberger; Olle Ringdén
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Transplantation 2007;84(4):551-4.
2007: Katarina Le Blanc; H Samuelsson; B Gustafsson; Mats Remberger; Berit Sundberg; J Arvidson; P Ljungman; Helena Lönnies; S Nava; Olle Ringdén
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
Leukemia 2007;21(8):1733-8.
2007: Olle Ringdén; Mats Remberger; Petter Svenberg; Britt-Marie Svahn; Göran Dahllöf; B Gustafsson; Zuzana Hassan; Brigitta Omazic; Mehmet Uzunel; Johan Aschan; Lisbeth Barkholt; Jacek Winiarski; Per Ljungman; Jonas Mattsson
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Bone marrow transplantation 2007;39(7):383-8.
2006: Jonas Mattsson; S Westin; S Edlund; Mats Remberger
Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease.
Bone marrow transplantation 2006;38(9):629-33.
2006: Mehmet Uzunel; Mats Remberger; Darius Sairafi; Zuzana Hassan; Jonas Mattsson; Brigitta Omazic; Lisbeth Barkholt; Olle Ringdén
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Transplantation 2006;82(7):913-9.
2006: Mikael Sundin; Katarina Le Blanc; Olle Ringdén; Lisbeth Barkholt; Brigitta Omazic; Christina Lergin; Victor Levitsky; Mats Remberger
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
Haematologica 2006;91(8):1059-67.
2006: Olle Ringdén; Petter Svenberg; Katarina Le Blanc; Jonas Mattsson; Mats Remberger
Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
Bone marrow transplantation 2006;38(4):321-2.
2006: Britt-Marie Svahn; Ole Alvin; Olle Ringdén; Ann Gardulf; Mats Remberger
Costs of allogeneic hematopoietic stem cell transplantation.
Transplantation 2006;82(2):147-53.
2006: Britt-Marie Svahn; Olle Ringdén; Mats Remberger
Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades.
Transplantation 2006;81(11):1600-3.
2006: Olle Ringdén; Mehmet Uzunel; Ida Rasmusson; Mats Remberger; Berit Sundberg; Helena Lönnies; Hanns-Ulrich Marschall; Aldona Dlugosz; Attila Szakos; Zuzana Hassan; Brigitta Omazic; Johan Aschan; Lisbeth Barkholt; Katarina Le Blanc
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
Transplantation 2006;81(10):1390-7.
2006: Olle Ringdén; Mats Remberger; Britt-Marie Svahn; Lisbeth Barkholt; Jonas Mattsson; Johan Aschan; Katarina Le Blanc; Britt Gustafsson; Zuzana Hassan; Brigitta Omazic; Petter Svenberg; Göran Solders; Ulrika von Döbeln; Jacek Winiarski; Per Ljungman; Gunilla Malm
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.
Transplantation 2006;81(5):718-25.
2006: Géraldine Giraud; Gordana Bogdanovic; Peter Priftakis; Mats Remberger; Britt-Marie Svahn; Lisbeth Barkholt; Olle Ringden; Jacek Winiarski; Per Ljungman; Tina Dalianis
The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen.
Haematologica 2006;91(3):401-4.
2006: Réka Conrad; Mats Remberger; Kerstin Cederlund; Patrik Hentschke; Berit Sundberg; Olle Ringdén; Lisbeth Barkholt
Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(3):346-54.
2006: Ulrica Forslöw; Jonas Mattsson; Olle Ringden; Julius Klominek; Mats Remberger
Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.
Scandinavian journal of infectious diseases 2006;38(11-12):970-6.
2005: Britt-Marie Svahn; Olle Ringdén; Mats Remberger
Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2005;36(6):511-6.
2005: Marie Jaksch; Mehmet Uzunel; Mats Remberger; Berit Sundberg; Jonas Mattsson
Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV.
Clinical transplantation 2005;19(3):346-9.
2005: Jonas Mattsson; Mats Remberger; Olof Andersson; Berit Sundberg; Magnus Nord
Decreased serum levels of clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation.
Transplantation 2005;79(10):1411-6.
2005: Olle T H Ringdén; Katarina Le Blanc; Mats Remberger
Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications.
Experimental hematology 2005;33(5):505-12.
2005: Marie Jaksch; Mats Remberger; Jonas Mattsson
Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):280-7.
2005: Patrik Hentschke; Brigitta Omazic; Jonas Mattsson; Ingrid Näsman-Björk; Inger Lundkvist; D Gigliotti; Lisbeth Barkholt; Olle Ringdén; Mats Remberger
T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
Scandinavian journal of immunology 2005;61(3):285-94.
2005: Mats Remberger; Dietrich W Beelen; Axel A Fauser; Nadezda Basara; Oliver Basu; Olle Ringdén
Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors.
Blood 2005;105(2):548-51.
2004: Petter Svenberg; Mats Remberger; Johan Svennilson; Jonas Mattsson; Katarina Leblanc; Britt Gustafsson; Johan Aschan; Lisbeth Barkholt; Jacek Winiarski; Per Ljungman; Olle Ringdén
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):877-82.
2004: Gordana Bogdanovic; Peter Priftakis; Géraldine Giraud; M Kuzniar; R Ferraldeschi; Parviz Kokhaei; Håkan Mellstedt; Mats Remberger; Per Ljungman; Jacek Winiarski; Tina Dalianis
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation.
Journal of clinical microbiology 2004;42(11):5394-6.
2004: Marie Schaffer; Karl-Johan Malmberg; Olle Ringdén; Hans-Gustaf Ljunggren; Mats Remberger
Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(7):1081-5.
2004: Katarina Le Blanc; Mats Remberger; Mehmet Uzunel; Jonas Mattsson; Lisbeth Barkholt; Olle Ringdén
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation.
Transplantation 2004;78(7):1014-20.
2004: Lisbeth Barkholt; Rimma Danielsson; Bertil Calissendorff; Leif Svensson; Reza Malihi; Mats Remberger; Mehmet Uzunel; Anders Thörne; Olle Ringdén
Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(5):697-703.
2004: Mats Remberger; Britt-Marie Svahn; Jonas Mattsson; Olle Ringdén
Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation.
Transplantation 2004;78(1):122-7.
2004: Michael Kiehl; Ludwig Kraut; Rainer Schwerdtfeger; Bernd Hertenstein; Mats Remberger; Nicolaus Kroeger; Mathias Stelljes; Martin Bornhaeuser; Hans Martin; Christoph Scheid; Arnold Ganser; Axel R Zander; Joachim Kienast; Gerhard Ehninger; Dieter Hoelzer; Volker Diehl; Axel A Fauser; Olle Ringden
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2816-25.
2004: Anna Nordlander; Jonas Mattsson; Olle Ringdén; Katarina Leblanc; Britt Gustafsson; Per Ljungman; Petter Svenberg; Johan Svennilson; Mats Remberger
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):195-203.
2004: Olle Ringdén; Marie Schaffer; Katarina Le Blanc; Ulla Persson; Dan Hauzenberger; Mohammad R Abedi; Olle Olerup; Per Ljungman; Mats Remberger
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):128-34.
2004: Marie Jaksch; Mats Remberger; Jonas Mattsson
Increased immune transcript levels are correlated with acute graft-versus-host disease and cytomegalovirus response after allogeneic stem cell transplantation.
Transplantation 2004;77(2):195-200.
2003: Katarina Le Blanc; Olle Ringdén; Mats Remberger
A low body mass index is correlated with poor survival after allogeneic stem cell transplantation.
Haematologica 2003;88(9):1044-52.
2003: Marie Schaffer; A Aldener-Cannavá; Mats Remberger; Olle Ringdén; Olle Olerup
Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation.
Tissue antigens 2003;62(3):243-50.
2003: Jonas Mattsson; Mehmet Uzunel; Mats Remberger; Moustapha Hassan
Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation.
Bone marrow transplantation 2003;32(5):477-83.
2003: Mats Remberger; N Naseh; Johan Aschan; Lisbeth Barkholt; K LeBlanc; P Svennberg; Olle Ringdén
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
Bone marrow transplantation 2003;32(2):217-23.
2003: Mats Remberger; Marie Jaksch; Mehmet Uzunel; Jonas Mattsson
Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation.
European journal of haematology 2003;70(6):384-91.
2003: Johan Svennilson; Mats Remberger; Olle Ringdén
Risk factors for moderate-to-severe acute graft-vs.-host disease after allogeneic stem cell transplantation in children.
Pediatric transplantation 2003;7(2):130-6.
2003: Marie Jaksch; Mehmet Uzunel; G Martinez Cangana; Mats Remberger; Jonas Mattsson
Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation.
Bone marrow transplantation 2003;31(3):183-90.
2003: Patrik Hentschke; Lisbeth Barkholt; Mehmet Uzunel; Jonas Mattsson; Peter Wersäll; Pavel Pisa; J Martola; Nils Albiin; Annika Wernerson; M Söderberg; Mats Remberger; Anders Thörne; Olle Ringdén
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
Bone marrow transplantation 2003;31(4):253-61.
2002: Britt-Marie Svahn; Mats Remberger; Karl-Erik Myrbäck; Katarina Holmberg; Britta Eriksson; Patrik Hentschke; Johan Aschan; Lisbeth Barkholt; Olle Ringdén
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Blood 2002;100(13):4317-24.
2002: Mats Remberger; Jonas Mattsson; Patrik Hentschke; Johan Aschan; Lisbeth Barkholt; Johan Svennilson; Per Ljungman; Olle Ringdén
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors.
Bone marrow transplantation 2002;30(11):761-8.
2002: Mats Remberger; Ulla Persson; Dan Hauzenberger; Olle Ringdén
An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):751-9.
2002: Tapani Ruutu; Britta Eriksson; Kari Remes; Eeva Juvonen; Liisa Volin; Mats Remberger; Terttu Parkkali; Hans Hägglund; Olle Ringdén
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
Blood 2002;100(6):1977-83.
2002: Patrik Hentschke; Mats Remberger; Jonas Mattsson; Lisbeth Barkholt; Johan Aschan; Per Ljungman; Olle Ringdén
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factors.
Transplantation 2002;73(6):930-6.
2002: Mats Remberger; B Storer; Olle Ringdén; C Anasetti
Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors.
Bone marrow transplantation 2002;29(5):391-7.
2002: Mats Remberger; Gunilla Kumlien; Johan Aschan; Lisbeth Barkholt; Patrik Hentschke; Per Ljungman; Jonas Mattsson; Johan Svennilson; Olle Ringdén
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(12):674-82.
2001: Gérard Socié; R A Clift; Didier Blaise; Agnès Devergie; Olle Ringden; P J Martin; Mats Remberger; H Joachim Deeg; Tapani Ruutu; Mauricette Michallet; KM Sullivan; Sylvie Chevret
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
Blood 2001;98(13):3569-74.
2001: Mehmet Uzunel; Jonas Mattsson; Marie Jaksch; Mats Remberger; Olle Ringdén
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia.
Blood 2001;98(6):1982-4.
2001: Mats Remberger; Olle Ringdén; Igor Wolfgang Blau; Hellmut D Ottinger; Bernhard Kremens; Michael Kiehl; Johan Aschan; Dietrich W Beelen; Nadezda Basara; Gunilla Kumlien; Axel A Fauser; Volker Runde
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.
Blood 2001;98(6):1739-45.
2001: Mats Remberger; Johan Aschan; Lisbeth Barkholt; J Tollemar; Olle Ringdén
Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.
Clinical transplantation 2001;15(3):147-53.
2001: Vanderson Rocha; J Cornish; E L Sievers; Alexandra H Filipovich; Franco Locatelli; Christina Peters; Mats Remberger; Gérard Michel; William Arcese; Sandro Dallorso; K Tiedemann; Alessandro Busca; K W Chan; S Kato; Juan Ortega; Marcus R Vowels; A Zander; G Souillet; A Oakill; Ann Woolfrey; A L Pay; A Green; Federico Garnier; Irina Ionescu; Peter Wernet; Girolamo Sirchia; Pablo Rubinstein; Sylvie Chevret; Eliane Gluckman
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
Blood 2001;97(10):2962-71.
2001: Jonas Mattsson; Mehmet Uzunel; Mats Remberger; Olle Ringdén
T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation.
Transplantation 2001;71(3):433-9.
2001: Mats Remberger; Johan Aschan; B Lönnqvist; S Carlens; B Gustafsson; Patrik Hentschke; S Klaesson; Jonas Mattsson; Per Ljungman; Olle Ringdén
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1769-70.
2001: S Carlens; Mats Remberger; Johan Aschan; Olle Ringdén
The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):31-8.
2001: Mats Remberger; Johan Aschan; B Lönnqvist; S Carlens; B Gustafsson; Patrik Hentschke; S Klaesson; Jonas Mattsson; Per Ljungman; Olle Ringdén
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
European journal of haematology 2001;66(1):50-6.
2001: Jonas Mattsson; Mehmet Uzunel; Mats Remberger; L Tammik; Brigitta Omazic; Victor Levitsky; Jie-Zhi Zou; Patrik Hentschke; Olle Ringdén
Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
Clinical and experimental immunology 2001;123(1):162-9.
2000: S Carlens; M Gilljam; Mats Remberger; Johan Aschan; Birger Christensson; M Sirac Dilber
Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution.
Experimental hematology 2000;28(10):1137-46.
2000: Olle Ringdén; Gunnar Söderdahl; Jonas Mattsson; Mehmet Uzunel; Mats Remberger; Patrik Hentschke; Hans Hägglund; Elda Sparrelid; A Elmhorn-Rosenborg; Frans Duraj; Henrik Zetterquist; Bo-Göran Ericzon
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
Transplantation 2000;69(10):2043-8.
2000: Olle Ringdén; Mats Remberger; Volker Runde; Martin Bornhäuser; Igor Wolfgang Blau; Nadezda Basara; Kristina Hölig; Dietrich W Beelen; Hans Hägglund; Oliver Basu; Gerhard Ehninger; Axel A Fauser
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.
Bone marrow transplantation 2000;25 Suppl 2():S6-8.
2000: Olle Ringdén; Mats Remberger; S Lehmann; Patrik Hentschke; Jonas Mattsson; S Klaesson; Johan Aschan
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.
Bone marrow transplantation 2000;25(9):993-6.
2000: Jonas Mattsson; Mehmet Uzunel; Mats Remberger; P Ljungman; E Kimby; Olle Ringdén; Henrik Zetterquist
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease.
Leukemia 2000;14(2):247-54.
2000: I N Björk; C Brissac; Mats Remberger; Jonas Mattsson; S Klaesson; Olle Ringdén; J Stewart; Inger Lundkvist
Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).
Clinical and experimental immunology 2000;119(1):240-9.
1999: Johan Aschan; S Carlens; Hans Hägglund; S Klaesson; Jonas Mattsson; Mats Remberger
Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease: a long-term follow-up.
Clinical transplantation 1999;13(6):512-9.
1999: Hans Hägglund; Olle Ringdén; S Oman; Mats Remberger; S Carlens; Jonas Mattsson
A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation.
Bone marrow transplantation 1999;24(8):831-6.
1999: Mats Remberger; Britt-Marie Svahn; Patrik Hentschke; Christina Löfgren; Olle Ringdén
Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation.
Bone marrow transplantation 1999;24(8):823-30.
1999: S Carlens; Johan Aschan; Mats Remberger; M Sirac Dilber; Olle Ringdén
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia.
Bone marrow transplantation 1999;24(6):629-35.
1999: Johan Aschan; Mats Remberger; S Carlens; Jonas Mattsson; M Sirac Dilber; B Lönnqvist; Bo Björkstrand
Unrelated donor stem cell transplantation after autologous transplantation: experience of a single center.
Bone marrow transplantation 1999;24(3):279-82.
1999: Olle Ringdén; Mats Remberger; Volker Runde; Martin Bornhäuser; Igor Wolfgang Blau; Nadezda Basara; Kristina Hölig; Dietrich W Beelen; Hans Hägglund; Oliver Basu; Gerhard Ehninger; Axel A Fauser
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Blood 1999;94(2):455-64.
1999: Olle Ringdén; Mats Remberger; Tapani Ruutu; J Nikoskelainen; Liisa Volin; Lars L Vindeløv; Terttu Parkkali; Stig Lenhoff; B Sallerfors; L Mellander; Per Ljungman; Niels Jacobsen
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.
Blood 1999;93(7):2196-201.
1998: Hans Hägglund; Mats Remberger; S Klaesson; B Lönnqvist; Per Ljungman; Olle Ringdén
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.
Blood 1998;92(12):4568-72.
1998: Elda Sparrelid; Hans Hägglund; Mats Remberger; Olle Ringdén; B Lönnqvist; Per Ljungman; Jan Andersson
Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
Bone marrow transplantation 1998;22(8):795-800.
1998: S Carlens; Olle Ringdén; Mats Remberger; B Lönnqvist; Hans Hägglund; S Klaesson; Jonas Mattsson; Britt-Marie Svahn; Jacek Winiarski; Per Ljungman; Johan Aschan
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Bone marrow transplantation 1998;22(8):755-61.
1998: Olle Ringdén; Mats Remberger; S Carlens; H Hagglund; Jonas Mattsson; Johan Aschan; B Lönnqvist; S Klaesson; Jacek Winiarski; Tina Dalianis; Olle Olerup; Elda Sparrelid; A Elmhorn-Rosenborg; Britt-Marie Svahn; Per Ljungman
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
Transplantation 1998;66(5):620-5.
1998: Hans Hägglund; Olle Ringdén; Mats Remberger; B Lönnqvist; Elda Sparrelid; L Tammik; G Kumlien
Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow.
Bone marrow transplantation 1998;22(2):131-6.
1998: Mats Remberger; Olle Ringdén; Per Ljungman; Hans Hägglund; Jacek Winiarski; B Lönnqvist; Johan Aschan
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(1):73-8.
1998: S Carlens; Olle Ringdén; Johan Aschan; Hans Hägglund; Per Ljungman; Jonas Mattsson; Mats Remberger
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Clinical transplantation 1998;12(2):84-92.
1998: Hans Hägglund; Olle Ringdén; B Agren; Lars Wennberg; Mats Remberger; L Rundquist; Britt-Marie Svahn; P Aspelin
Intraosseous compared to intravenous infusion of allogeneic bone marrow.
Bone marrow transplantation 1998;21(4):331-5.
1998: Gunnar Söderdahl; C Tammik; Mats Remberger; Olle Ringdén
Cadaveric bone marrow and spleen cells for transplantation.
Bone marrow transplantation 1998;21(1):79-84.
1998: Olle Ringdén; Mats Remberger; Jonas Mattsson; Johan Aschan; S Carlens; Hans Hägglund; B Lönnqvist; Elda Sparrelid; Per Ljungman
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age.
Bone marrow transplantation 1998;21(1):43-9.
1997: Olle Ringdén; E E Andström; Mats Remberger; Göran Dahllöf; Britt-Marie Svahn; J Tollemar
Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Pediatric transplantation 1997;1(2):124-9.
1997: S Carlens; Olle Ringdén; Mats Remberger; Jonas Mattsson; Johan Aschan; Hans Hägglund; Per Ljungman
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia.
Transplantation proceedings 1997;29(7):3147-9.
1997: Olle Ringdén; Mats Remberger; Jonas Mattsson; Johan Aschan; Hans Hägglund; S Carlens; B Lönnqvist; Elda Sparrelid; Per Ljungman
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
Transplantation proceedings 1997;29(7):3145-6.
1997: Mats Remberger; O Ringdén
Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver.
European journal of haematology 1997;59(4):254-62.
1997: Göran Dahllöf; Mats Bågesund; Mats Remberger; Olle Ringdén
Risk factors for salivary dysfunction in children 1 year after bone marrow transplantation.
Oral oncology 1997;33(5):327-31.
1997: Jonas Mattsson; Olle Ringdén; Johan Aschan; Lisbeth Barkholt; Tina Dalianis; Hans Hägglund; Per Ljungman; B Lönnqvist; J Tollemar; Jacek Winiarski; Mats Remberger
A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.
Transplantation proceedings 1997;29(1-2):735-6.
1997: Gunnar Söderdahl; C Tammik; Mats Remberger; J Sandberg; G Tufveson; J Tollemar; Olle Ringdén
Immune markers and hematopoiesis of cadaveric bone marrow for transplantation.
Transplantation proceedings 1997;29(1-2):714-5.
1996: E E Andström; Olle Ringdén; Mats Remberger; Britt-Marie Svahn; J Tollemar
Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.
Mycoses 1996;39(5-6):185-93.
1996: Jacek Winiarski; Olle Ringdén; Mats Remberger; Tina Dalianis; Per Ljungman; B Borgström
Bone marrow transplantation in children using unrelated donors at Huddinge Hospital.
Acta paediatrica (Oslo, Norway : 1992) 1996;85(3):327-35.
1995: Mats Remberger; O Ringdén
Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Transplantation 1995;60(11):1293-9.
1995: Hans Hägglund; L Boström; Mats Remberger; P Ljungman; B Nilsson; O Ringdén
Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.
Bone marrow transplantation 1995;16(6):747-53.
1995: Johan Aschan; O Ringdén; Per Ljungman; Hans Hägglund; S Klaesson; Tina Dalianis; Mats Remberger
Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
Transplantation proceedings 1995;27(6):3531-2.
1995: Elda Sparrelid; Hans Hägglund; Mats Remberger; Per Ljungman; A S Malmborg; Jacek Winiarski; J Andersson; Olle Ringdén
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
Transplantation proceedings 1995;27(6):3530.
1995: Olle Ringdén; Mats Remberger; U Persson; Per Ljungman; A Aldener; E Andström; Johan Aschan; P Bolme; G Dahllöf; Tina Dalianis
Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
Bone marrow transplantation 1995;15(4):619-25.
1995: Mats Remberger; O Ringden; L Markling
TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.
Bone marrow transplantation 1995;15(1):99-104.
1994: Olle Ringdén; Mats Remberger; Johan Aschan; P Lungman; B Lönnqvist; L Markling
Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation 1994;58(8):887-91.
1994: Johan Aschan; Olle Ringdén; E Andström; Per Ljungman; B Lönnqvist; Mats Remberger
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Bone marrow transplantation 1994;14(1):79-87.
1994: Olle Ringdén; Mats Remberger; U Persson; Per Ljungman; Johan Aschan; P Bolme; G Dahllöf; Tina Dalianis; G Gahrton; B Lönnqvist
[New facts about bone marrow transplantation. An unrelated donor is as good as a related one].
Läkartidningen 1994;91(26-27):2577-82.
1994: Olle Ringdén; Tapani Ruutu; Mats Remberger; J Nikoskelainen; Liisa Volin; L Vindeløv; Terttu Parkkali; Stig Lenhoff; B Sallerfors; Per Ljungman
A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
Transplantation proceedings 1994;26(3):1831-2.
1994: Mats Remberger; O Ringden; Johan Aschan; Per Ljungman; B Lönnqvist; L Markling
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation proceedings 1994;26(3):1829-30.
1994: Johan Aschan; Olle Ringdén; E Andström; Per Ljungman; Mats Remberger
Prevention of graft-versus-host disease on an individual basis.
Transplantation proceedings 1994;26(3):1823-4.
1994: Hans Hägglund; L Boström; O Ringdén; B Nilsson; Mats Remberger
Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
Transplantation proceedings 1994;26(3):1821-2.
1994: Olle Ringdén; Tapani Ruutu; Mats Remberger; J Nikoskelainen; Liisa Volin; L Vindeløv; Terttu Parkkali; Stig Lenhoff; B Sallerfors; Per Ljungman
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.
Blood 1994;83(9):2723-30.
1994: Olle Ringdén; E Andström; Mats Remberger; Britt-Marie Svahn; J Tollemar
Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.
Bone marrow transplantation 1994;14 Suppl 5():S10-4.
1993: S Klaesson; Olle Ringdén; L Markling; Mats Remberger; Inger Lundkvist
Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.
Scandinavian journal of immunology 1993;38(5):477-84.